Patent ID: 8486386
Filing Date: 2013-07-16
Classification: A61K,A61L,A61P

Abstract:
1. A kit comprising: a first syringe containing a mixture of a first functionalized polyethylene glycol polymer and an extracellular matrix protein having at least one cell-adhesion site in a first buffer at physiological osmolality; a second syringe containing a second buffer at a concentration from 140 millimolar to 150 millimolar and a physiological osmolality; and a dual bore catheter configured to accept the first syringe and the second syringe through respective bores and configured for delivery of the mixture and the second buffer to a post-myocardial infarct region, wherein the physiological osmolality is in a range from 280 mOsm/kg H wherein the extracellular matrix protein is selected from the group consisting of gelatin, laminin, elastin, and an arginine-glycine-aspartic acid peptide sequence.